EQUIFAX INC — Director's Dealing 2025

Feb 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2025-02-13

Reporting Person: Begor Mark W (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-13	Common Stock	M	22161.0000	$175.4800	Acquired	164404.0000	Direct
2025-02-13	Common Stock	S	595.0000	$253.5968	Disposed	163809.0000	Direct
2025-02-13	Common Stock	S	1402.0000	$256.3083	Disposed	162407.0000	Direct
2025-02-13	Common Stock	S	1600.0000	$252.3775	Disposed	160807.0000	Direct
2025-02-13	Common Stock	S	5214.0000	$255.2708	Disposed	155593.0000	Direct
2025-02-13	Common Stock	S	6199.0000	$250.7382	Disposed	149394.0000	Direct
2025-02-13	Common Stock	S	7151.0000	$251.5952	Disposed	142243.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-13	Stock Option/Right to Buy	$175.4800	M	22161.0000	Disposed	2026-02-21	Common Stock (22161.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	43382.0000	Indirect
Common Stock	20025.0000	Indirect
Common Stock	24125.0000	Indirect
Common Stock	24225.0000	Indirect
Common Stock	12333.0000	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.

F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 147 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

F3: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $253.26 to $254.19, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F4: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $255.89 to $256.78, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $252.24 to $252.61, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $254.815 to $255.77, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F7: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $250.095 to $251.03, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F8: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $251.17 to $252.14, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F9: The option vested in three equal annual increments beginning 2/21/2021.